24
2016.9
The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes patches of skin redness and f…
15
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also ap…
Total 1 Pages/ Page 1
020-81960175-800
@Catochem
CATO72404463info@cato-chem.com
standards@cato-chem.com
Back to the top page
